Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 25 | 2024 | 585 | 3.570 |
Why?
|
| Diabetes Mellitus | 7 | 2024 | 412 | 2.210 |
Why?
|
| Hypertension | 9 | 2024 | 960 | 1.810 |
Why?
|
| Low Back Pain | 7 | 2022 | 45 | 1.320 |
Why?
|
| Automobile Driving | 5 | 2023 | 24 | 1.240 |
Why?
|
| Rural Population | 3 | 2024 | 277 | 1.130 |
Why?
|
| Medicare | 2 | 2024 | 206 | 1.030 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 195 | 1.020 |
Why?
|
| United States | 29 | 2024 | 3976 | 1.000 |
Why?
|
| Humans | 83 | 2024 | 32114 | 1.000 |
Why?
|
| Licensure | 4 | 2023 | 5 | 0.900 |
Why?
|
| Urban Population | 1 | 2024 | 90 | 0.900 |
Why?
|
| Risk Factors | 24 | 2024 | 3880 | 0.890 |
Why?
|
| Health Status Disparities | 6 | 2023 | 131 | 0.870 |
Why?
|
| Female | 53 | 2024 | 20015 | 0.790 |
Why?
|
| Aged | 28 | 2024 | 10314 | 0.730 |
Why?
|
| Male | 43 | 2024 | 19217 | 0.690 |
Why?
|
| Adult | 30 | 2024 | 9380 | 0.630 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 120 | 0.600 |
Why?
|
| Cohort Studies | 13 | 2024 | 1817 | 0.600 |
Why?
|
| Incidence | 13 | 2024 | 1199 | 0.590 |
Why?
|
| Social Class | 7 | 2023 | 90 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 1428 | 0.580 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 128 | 0.540 |
Why?
|
| Middle Aged | 27 | 2024 | 11839 | 0.510 |
Why?
|
| Dental Hygienists | 1 | 2014 | 1 | 0.500 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 5 | 0.490 |
Why?
|
| Unsafe Sex | 1 | 2014 | 23 | 0.480 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 238 | 0.480 |
Why?
|
| Longitudinal Studies | 12 | 2023 | 770 | 0.460 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 253 | 0.450 |
Why?
|
| Public Health | 1 | 2014 | 89 | 0.450 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 1128 | 0.440 |
Why?
|
| Protein Precursors | 2 | 2024 | 22 | 0.430 |
Why?
|
| Students | 1 | 2014 | 178 | 0.430 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 184 | 0.430 |
Why?
|
| Child Restraint Systems | 2 | 2021 | 3 | 0.370 |
Why?
|
| Models, Statistical | 3 | 2023 | 175 | 0.370 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 232 | 0.370 |
Why?
|
| Coronary Disease | 3 | 2022 | 211 | 0.360 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1542 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 291 | 0.350 |
Why?
|
| Dental Caries | 3 | 2019 | 22 | 0.340 |
Why?
|
| HIV Infections | 1 | 2014 | 395 | 0.340 |
Why?
|
| Prevalence | 5 | 2024 | 989 | 0.340 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 352 | 0.320 |
Why?
|
| Fertility | 3 | 2013 | 31 | 0.320 |
Why?
|
| Poisson Distribution | 3 | 2023 | 17 | 0.310 |
Why?
|
| DMF Index | 3 | 2019 | 6 | 0.310 |
Why?
|
| Residence Characteristics | 4 | 2022 | 202 | 0.310 |
Why?
|
| Prospective Studies | 9 | 2024 | 2283 | 0.280 |
Why?
|
| Computer Simulation | 5 | 2023 | 220 | 0.270 |
Why?
|
| Child | 10 | 2024 | 2442 | 0.270 |
Why?
|
| Socioeconomic Factors | 6 | 2023 | 429 | 0.260 |
Why?
|
| Enkephalins | 2 | 2024 | 10 | 0.260 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 3990 | 0.260 |
Why?
|
| Cognition | 3 | 2024 | 556 | 0.250 |
Why?
|
| Regression Analysis | 2 | 2016 | 293 | 0.250 |
Why?
|
| Diet | 6 | 2023 | 391 | 0.240 |
Why?
|
| Mental Health | 2 | 2023 | 119 | 0.240 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2024 | 27 | 0.230 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2024 | 58 | 0.220 |
Why?
|
| Ovulation Detection | 2 | 2013 | 2 | 0.220 |
Why?
|
| Independent Living | 1 | 2024 | 100 | 0.220 |
Why?
|
| Cognition Disorders | 2 | 2024 | 385 | 0.220 |
Why?
|
| Sleep | 2 | 2021 | 92 | 0.210 |
Why?
|
| Pregnancy | 8 | 2021 | 997 | 0.210 |
Why?
|
| Caregivers | 1 | 2024 | 114 | 0.210 |
Why?
|
| Health Behavior | 2 | 2021 | 236 | 0.210 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 257 | 0.210 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 181 | 0.210 |
Why?
|
| Neuropeptides | 1 | 2022 | 17 | 0.200 |
Why?
|
| Air Pollution | 1 | 2021 | 18 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2021 | 24 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2022 | 399 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3510 | 0.190 |
Why?
|
| Sex Factors | 5 | 2021 | 667 | 0.190 |
Why?
|
| Firearms | 1 | 2021 | 8 | 0.190 |
Why?
|
| Seat Belts | 1 | 2021 | 17 | 0.190 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 66 | 0.190 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 881 | 0.190 |
Why?
|
| Geography | 4 | 2021 | 35 | 0.190 |
Why?
|
| Adolescent | 6 | 2023 | 3568 | 0.190 |
Why?
|
| Sports | 1 | 2021 | 36 | 0.180 |
Why?
|
| Aggression | 1 | 2020 | 30 | 0.180 |
Why?
|
| Soccer | 1 | 2020 | 19 | 0.180 |
Why?
|
| Depression | 2 | 2022 | 445 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 36 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2020 | 173 | 0.170 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 105 | 0.170 |
Why?
|
| Athletic Injuries | 1 | 2020 | 83 | 0.170 |
Why?
|
| Area Under Curve | 1 | 2019 | 93 | 0.170 |
Why?
|
| Selection Bias | 1 | 2019 | 13 | 0.170 |
Why?
|
| Algorithms | 1 | 2022 | 495 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2021 | 494 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 53 | 0.160 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 177 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 8 | 0.150 |
Why?
|
| Narcotics | 1 | 2017 | 16 | 0.150 |
Why?
|
| Pain Measurement | 4 | 2022 | 350 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2023 | 898 | 0.150 |
Why?
|
| Quality of Life | 1 | 2024 | 946 | 0.150 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 173 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 472 | 0.150 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 114 | 0.150 |
Why?
|
| Heart Failure | 1 | 2024 | 639 | 0.150 |
Why?
|
| Cocaine | 2 | 2017 | 256 | 0.150 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 12 | 0.140 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 125 | 0.140 |
Why?
|
| Bicycling | 1 | 2016 | 14 | 0.140 |
Why?
|
| Placenta Previa | 1 | 2016 | 2 | 0.140 |
Why?
|
| Time Factors | 5 | 2024 | 2151 | 0.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 13 | 0.140 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 13 | 0.130 |
Why?
|
| Exercise | 4 | 2023 | 673 | 0.130 |
Why?
|
| Binomial Distribution | 1 | 2015 | 2 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 58 | 0.130 |
Why?
|
| Risk Assessment | 5 | 2021 | 1429 | 0.130 |
Why?
|
| Accidents | 1 | 2015 | 4 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2015 | 9 | 0.130 |
Why?
|
| Premature Birth | 1 | 2016 | 66 | 0.130 |
Why?
|
| Young Adult | 4 | 2016 | 2665 | 0.130 |
Why?
|
| Dentin | 1 | 2014 | 1 | 0.120 |
Why?
|
| Calcium Hydroxide | 1 | 2014 | 2 | 0.120 |
Why?
|
| Silicates | 1 | 2014 | 3 | 0.120 |
Why?
|
| Aluminum Compounds | 1 | 2014 | 4 | 0.120 |
Why?
|
| Root Canal Filling Materials | 1 | 2014 | 3 | 0.120 |
Why?
|
| Calcium Compounds | 1 | 2014 | 9 | 0.120 |
Why?
|
| Dental Care for Aged | 1 | 2014 | 6 | 0.120 |
Why?
|
| Stereotyping | 1 | 2014 | 8 | 0.120 |
Why?
|
| Oxides | 1 | 2014 | 16 | 0.120 |
Why?
|
| Lead | 1 | 2014 | 6 | 0.120 |
Why?
|
| Homes for the Aged | 1 | 2014 | 20 | 0.120 |
Why?
|
| Harm Reduction | 1 | 2014 | 14 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2014 | 48 | 0.120 |
Why?
|
| Nursing Homes | 1 | 2014 | 42 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 55 | 0.120 |
Why?
|
| Inflammation | 3 | 2022 | 530 | 0.120 |
Why?
|
| Cervix Mucus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Parents | 3 | 2023 | 147 | 0.110 |
Why?
|
| West Virginia | 3 | 2020 | 16 | 0.110 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2012 | 1 | 0.110 |
Why?
|
| Lubricants | 1 | 2012 | 1 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 753 | 0.100 |
Why?
|
| Albuminuria | 2 | 2024 | 181 | 0.100 |
Why?
|
| Age Factors | 3 | 2020 | 1189 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 144 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 392 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2020 | 923 | 0.100 |
Why?
|
| Vagina | 1 | 2012 | 59 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 371 | 0.100 |
Why?
|
| Pregnancy Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 23 | 0.100 |
Why?
|
| Molar, Third | 1 | 2011 | 2 | 0.100 |
Why?
|
| Tooth Extraction | 1 | 2011 | 18 | 0.100 |
Why?
|
| Minocycline | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cryotherapy | 1 | 2011 | 13 | 0.100 |
Why?
|
| Neoplasms | 1 | 2019 | 728 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 66 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2021 | 1270 | 0.090 |
Why?
|
| Alabama | 2 | 2021 | 41 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2017 | 672 | 0.090 |
Why?
|
| Vitamin D | 1 | 2011 | 184 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 357 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 178 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 324 | 0.080 |
Why?
|
| Forensic Toxicology | 2 | 2020 | 3 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 510 | 0.070 |
Why?
|
| Logistic Models | 2 | 2021 | 783 | 0.070 |
Why?
|
| Dental Caries Susceptibility | 2 | 2017 | 2 | 0.070 |
Why?
|
| Educational Status | 2 | 2018 | 181 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 876 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 765 | 0.060 |
Why?
|
| Infant | 2 | 2019 | 1062 | 0.060 |
Why?
|
| Glasgow Outcome Scale | 1 | 2024 | 2 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 48 | 0.060 |
Why?
|
| Executive Function | 1 | 2024 | 57 | 0.060 |
Why?
|
| Snoring | 1 | 2024 | 10 | 0.060 |
Why?
|
| Transportation | 1 | 2023 | 13 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 135 | 0.060 |
Why?
|
| Population Dynamics | 1 | 2023 | 6 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2023 | 43 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2023 | 14 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 10 | 0.050 |
Why?
|
| Social Environment | 1 | 2023 | 79 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 247 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 83 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2022 | 18 | 0.050 |
Why?
|
| Censuses | 1 | 2022 | 10 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Neurotensin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 10 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 80 | 0.050 |
Why?
|
| Cities | 1 | 2021 | 7 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 137 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 308 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2265 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2021 | 31 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2023 | 221 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 174 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 8 | 0.050 |
Why?
|
| Food Supply | 1 | 2022 | 67 | 0.050 |
Why?
|
| Income | 1 | 2021 | 63 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 104 | 0.050 |
Why?
|
| Movement | 1 | 2021 | 51 | 0.050 |
Why?
|
| Child Behavior | 1 | 2021 | 27 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2021 | 92 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2021 | 91 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2022 | 141 | 0.050 |
Why?
|
| Coroners and Medical Examiners | 1 | 2020 | 6 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 294 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 101 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 95 | 0.040 |
Why?
|
| Video Recording | 1 | 2020 | 59 | 0.040 |
Why?
|
| Parenting | 1 | 2020 | 23 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 408 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2020 | 46 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 547 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 191 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 206 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 240 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 76 | 0.040 |
Why?
|
| Physicians, Family | 1 | 2019 | 16 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 474 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 449 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2018 | 12 | 0.040 |
Why?
|
| Japan | 1 | 2018 | 17 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 232 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 90 | 0.040 |
Why?
|
| American Heart Association | 1 | 2019 | 87 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 142 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 566 | 0.040 |
Why?
|
| Opiate Alkaloids | 1 | 2017 | 1 | 0.040 |
Why?
|
| Meconium | 1 | 2017 | 2 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 7 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 236 | 0.040 |
Why?
|
| Biological Assay | 1 | 2017 | 19 | 0.040 |
Why?
|
| Cardiology | 1 | 2019 | 99 | 0.040 |
Why?
|
| Dentifrices | 1 | 2017 | 1 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 92 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 228 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 125 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 582 | 0.030 |
Why?
|
| Hallucinogens | 1 | 2016 | 12 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 1176 | 0.030 |
Why?
|
| Mouthwashes | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 121 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 255 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 408 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 845 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 79 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 297 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 946 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 8 | 0.030 |
Why?
|
| Tooth, Deciduous | 1 | 2014 | 3 | 0.030 |
Why?
|
| Rheology | 1 | 2014 | 30 | 0.030 |
Why?
|
| Particle Size | 1 | 2014 | 46 | 0.030 |
Why?
|
| Urban Health | 1 | 2014 | 15 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 315 | 0.030 |
Why?
|
| Dental Care | 1 | 2014 | 18 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 98 | 0.030 |
Why?
|
| Birth Weight | 1 | 2014 | 47 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 98 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 314 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 89 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2014 | 43 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2014 | 60 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 44 | 0.030 |
Why?
|
| Poverty | 1 | 2014 | 115 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 355 | 0.030 |
Why?
|
| Fertilization | 1 | 2013 | 5 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 148 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 226 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 166 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 51 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2012 | 9 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 11 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2019 | 766 | 0.030 |
Why?
|
| Creatinine | 1 | 2012 | 195 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 164 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 39 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2011 | 96 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 112 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2011 | 140 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 684 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 51 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 109 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 560 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 1538 | 0.020 |
Why?
|